InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.00%
)
US TECH 100
19,216.00
(
0.01%
)
Dow Jones
39,127.80
(
0.00%
)
Brent Oil
85.22
(
0.88%
)
Bitcoin
61,733.24
(
1.51%
)
Post# of 426200
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ralphey

Send PM Follow Ignore
Followers 21
Posts 2539
Boards Moderated 0
Alias Born 12/07/2013

ralphey

Re: oneragman post# 113575

Monday, 09/04/2017 12:44:11 PM

Monday, September 04, 2017 12:44:11 PM

Post# of 426200
You missed the point - you are correct statins are the mainstay of treatment and you cannot deny people that treatment .... but ...I have numerous patients that are statin intolerant .... you use that group as a means of leveraging in on the statin market. Likelihood of success in statin naive people should be much higher
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!